Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ANVS
Stock Latest News
Company Announcements
Annovis Bio Hosts Regulation FD Investor Information Webinar
8d ago
8K
ANVS
Premium
The Fly
Annovis Bio reports open-label extension study for Parkinson’s disease patients
2M ago
ANVS
Premium
Company Announcements
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson’s Disease
2M ago
ANVS
Premium
Ratings
Annovis Bio Receives Buy Rating Amid Promising Phase 3 Trial Results and Strategic FDA Discussions for Buntanetap
3M ago
ANVS
Premium
The Fly
Annovis announces FDA meeting to discuss PDD program
3M ago
ANVS
Premium
The Fly
Annovis Bio announces biomarker data on amyloid co-pathology in Parkinson’s
3M ago
ANVS
Premium
Ratings
Annovis Bio’s Strategic Advances and Insider Confidence Drive Buy Rating Amid Promising Alzheimer’s Treatment Progress
3M ago
ANVS
Premium
Company Announcements
Annovis Bio Inc. Reports Q3 2025 Financial Results
3M ago
ANVS
Premium
The Fly
Annovis Bio reports Q3 EPS (37c) vs. (97c) last year
3M ago
ANVS
Premium
The Fly
Annovis Bio sees cash runway to 3Q26
3M ago
ANVS
Premium
Ratings
Optimistic Buy Rating for Annovis Bio Amid Promising Alzheimer’s Clinical Developments
3M ago
ANVS
Premium
The Fly
Annovis Bio says all 84 sites fully activated for Phase 3 study in early AD
3M ago
ANVS
Premium
Company Announcements
Annovis Bio Announces Securities Purchase Agreement
3M ago
8K
ANVS
Premium
The Fly
Annovis Bio prices 1.67M shares at $2.05 in registered direct offering
3M ago
ANVS
Premium
Company Announcements
Annovis Bio Announces $6M Stock Offering
4M ago
8K
ANVS
Premium
Ratings
Promising Potential of Annovis Bio’s Buntanetap in Alzheimer’s Treatment Justifies Buy Rating
4M ago
ANVS
Premium
The Fly
Annovis Bio prices 4M shares at $1.50 in registered direct offering
4M ago
ANVS
Premium
The Fly
Annovis Bio announces new results from Phase 2/3 AD study of buntanetap
4M ago
ANVS
Premium
The Fly
Annovis Bio appoints Guerin as Chief Financial Officer
4M ago
ANVS
Premium
The Fly
Annovis Bio announces publication of new article in Biomolecules on buntanetap
5M ago
ANVS
Premium
Company Announcements
Annovis Bio’s Promising Alzheimer’s Study: What Investors Need to Know
5M ago
ANVS
Premium
The Fly
Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright
5M ago
ANVS
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
